CRNX
Crinetics Pharmaceuticals Inc
NASDAQ: CRNX · HEALTHCARE · BIOTECHNOLOGY
$38.78
+0.88% today
Updated 2026-04-30
Market cap
$3.99B
P/E ratio
—
P/S ratio
519.04x
EPS (TTM)
$-4.95
Dividend yield
—
52W range
$26 – $58
Volume
1.1M
Crinetics Pharmaceuticals Inc (CRNX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $12.60M | $15.60M | $171.41M | $130.38M | $183.44M | $351.01M | $352.18M | $635.35M | $1.43B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — |
| Current assets | $12.37M | $15.16M | $166.68M | $123.34M | $177.49M | $344.72M | $345.18M | $574.15M | $1.38B |
| Total liabilities | $18.80M | $30.62M | $11.19M | $13.24M | $14.53M | $19.07M | $35.85M | $96.25M | $109.79M |
| Current liabilities | $890000.00 | $897000.00 | $7.92M | $8.34M | $10.49M | $15.99M | $27.72M | $43.94M | $59.68M |
| Long-term debt | $163000.00 | — | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-7.11M | $-16.27M | $-43.38M | $-93.80M | $-167.61M | $-275.25M | $-439.17M | $-653.70M | $-952.11M |
| Accounts receivable | $72000.00 | $734000.00 | $1.58M | $1.38M | $1.83M | $2.03M | $2.42M | $9.35M | $8.47M |
| Inventory | $98000.00 | $141000.00 | — | $-1.38M | $-1.83M | $-2.03M | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — |